Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Item
http://www.wikidata.org/entity/Q34736886
Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrationsStructural Basis for Regulation of Human Glucokinase by Glucokinase Regulatory ProteinCurcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinaseMetformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.Loss of AMP-activated protein kinase alpha2 subunit in mouse beta-cells impairs glucose-stimulated insulin secretion and inhibits their sensitivity to hypoglycaemia.A soluble guanylate cyclase-dependent mechanism is involved in the regulation of net hepatic glucose uptake by nitric oxide in vivo.Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategiesAMP-activated protein kinase suppresses matrix metalloproteinase-9 expression in mouse embryonic fibroblasts.Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity.Regulation of hepatic glucose uptake and storage in vivo.AMP-dependent kinase inhibits oxidative stress-induced caveolin-1 phosphorylation and endocytosis by suppressing the dissociation between c-Abl and Prdx1 proteins in endothelial cellsAMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations.5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-Monophosphate (AICAR), a Highly Conserved Purine Intermediate with Multiple Effects.
P2860

Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Item
http://www.wikidata.org/entity/Q34736886
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Inhibition of glucokinase tran ...... e/fructose-2,6-bisphosphatase.
@ast
Inhibition of glucokinase tran ...... e/fructose-2,6-bisphosphatase.
@en
Inhibition of glucokinase tran ...... e/fructose-2,6-bisphosphatase.
@nl
type
label
Inhibition of glucokinase tran ...... e/fructose-2,6-bisphosphatase.
@ast
Inhibition of glucokinase tran ...... e/fructose-2,6-bisphosphatase.
@en
Inhibition of glucokinase tran ...... e/fructose-2,6-bisphosphatase.
@nl
prefLabel
Inhibition of glucokinase tran ...... e/fructose-2,6-bisphosphatase.
@ast
Inhibition of glucokinase tran ...... e/fructose-2,6-bisphosphatase.
@en
Inhibition of glucokinase tran ...... e/fructose-2,6-bisphosphatase.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Inhibition of glucokinase tran ...... e/fructose-2,6-bisphosphatase.
@en
P2093
P2860
P304
P31
P356
10.1152/AJPREGU.00593.2007
P433
P478
P577
P5875
P698
P921